1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL CONTRAST MEDIA MARKET BY MEDIA TYPE
5.1. Introduction
5.2. Iodine-based
5.3. Barium-based
5.4. Gadolinium
5.5. Saline
6. GLOBAL CONTRAST MEDIA MARKET BY ADMINISTRATION ROUTE
6.1. Introduction
6.2. Oral
6.3. Enema
6.4. Intravenously/Intraraterially
7. GLOBAL CONTRAST MEDIA MARKET BY MODALITY
7.1. Introduction
7.2. X-Rays
7.3. Computed Tomography (CT)
7.4. Magnetic Resonance Imaging (MRI)
7.5. Ultrasound
8. GLOBAL CONTRAST MEDIA MARKET BY APPLICATION
8.1. Introduction
8.2. Cardiovascular disorders
8.3. Neurological disorders
8.4. Gastrointestinal disorders
8.5. Nephrology disorders
8.6. Cancer
9.. GLOBAL CONTRAST MEDIA MARKET BY END-USER
9.1. Introduction
9.2. Hospitals and Clinics
9.3. Diagnostic Centres
10. GLOBAL CONTRAST MEDIA MARKET BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. USA
10.2.2. Canada
10.2.3. Mexico
10.3. South America
10.3.1. Brazil
10.3.2 Argentina
10.3.3. Others
10.4. Europe
10.4.1. Germany
10.4.2. France
10.4.3. United Kingdom
10.4.4. Spain
10.4.5. Others
10.5. Middle East and Africa
10.5.1. Saudi Arabia
10.5.2. UAE
10.5.3. Others
10.6. Asia Pacific
10.6.1. China
10.6.2. India
10.6.3. Japan
10.6.4. South Korea
10.6.5. Indonesia
10.6.6. Thailand
10.6.7. Others
11. COMPETITIVE ENVIRONMENT AND ANALYSIS
11.1. Major Players and Strategy Analysis
11.2. Market Share Analysis
11.3. Mergers, Acquisitions, Agreements, and Collaborations
11.4. Competitive Dashboard
12. COMPANY PROFILES
12.1. Bayer AG
12.2. Bracco Imaging S.p.A.
12.3. GE HealthCare
12.4. Guerbet
12.5. Lantheus Medical Imaging, Inc.
12.6. Daiichi Sankyo Company
12.7. Jodas Expoim
12.8. Nano Therapeutics Pvt. Ltd.
13. APPENDIX
13.1. Currency
13.2. Assumptions
13.3. Base and Forecast Years Timeline
13.4. Key benefits for the stakeholders
13.5. Research Methodology
13.6. Abbreviations